Physician profile
Scott A Kolander
NPI 1942242748
$758.76
in general payments reported to CMS, 2019-2025
17 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.56 · 2020: $26.49 · 2021: $89.33 · 2022: $175 · 2023: $148 · 2024: $122 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $161.03 | 2019-2024 | |
| Novo Nordisk INC | $143.77 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $69.08 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Exact Sciences Corporation | $60.93 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $57.71 | 2022-2024 | Mounjaro, Jardiance, Trulicity |
| Glaxosmithkline, LLC. | $45.27 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $44.40 | 2020-2025 | Airsupra |
| Edwards Lifesciences Corporation | $32.89 | 2022 | |
| Biogen, INC. | $24.65 | 2021 | |
| Eisai INC. | $18.04 | 2021 | |
| Abbvie INC. | $16.27 | 2024 | |
| Janssen Pharmaceuticals, INC | $15.86 | 2019 | |
| Amgen INC. | $14.93 | 2022 | |
| Amarin Pharma, INC. | $14.34 | 2019 | |
| Dynavax Technologies Corporation | $14.07 | 2023 | Heplisav-B |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.18 | 2023 | Tradjenta, Jardiance |
| Novartis Pharmaceuticals Corporation | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Kolander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.